seqirus.com
Seqirus Worldwide
|
CSL Limited
Search
Include All CSL Behring Country Sites
About Seqirus Worldwide
Products
Newsroom
Careers
Contacts
Home
> Home
Our Products
With cutting-edge facilities, technologies and technical expertise, Seqirus will be a reliable supplier of seasonal influenza vaccine with the ability to rapidly respond to pandemic threats.
Read More >
Features
Welcome to Seqirus
In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second ...
News
Seqirus Begins Shipping 2017-2018 Influenza Vaccines to the U.S. Market
20-July-2017
Seqirus announced today it has begun shipping ...
Seqirus announces next major advancement in cell-based influenza vaccine technology
21-Jun-2017
Seqirus, a leading innovator in influenza ...
Seqirus receives FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
29-Aug-2016
Seqirus announced today that the US Food and ...
Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children
24-Aug-2016
Seqirus today announced results of two data ...